GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 744 filers reported holding GLAXOSMITHKLINE PLC in Q3 2017. The put-call ratio across all filers is 0.96 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $671,000 | -95.6% | 18,805 | -95.5% | 0.02% | -95.2% |
| Q4 2020 | $15,245,000 | -27.3% | 414,261 | -25.7% | 0.31% | -33.3% |
| Q3 2020 | $20,975,000 | -12.8% | 557,244 | -5.5% | 0.47% | -16.0% |
| Q2 2020 | $24,055,000 | +0.5% | 589,732 | -6.6% | 0.56% | -9.2% |
| Q1 2020 | $23,932,000 | -12.6% | 631,612 | +8.4% | 0.61% | +9.1% |
| Q4 2019 | $27,388,000 | +12.8% | 582,852 | +2.4% | 0.56% | +4.5% |
| Q3 2019 | $24,283,000 | +8.6% | 568,964 | +1.8% | 0.54% | +8.3% |
| Q2 2019 | $22,361,000 | -4.8% | 558,745 | -0.6% | 0.50% | -7.5% |
| Q1 2019 | $23,498,000 | +14.7% | 562,295 | +4.9% | 0.54% | +1.1% |
| Q4 2018 | $20,488,000 | -3.6% | 536,197 | +1.3% | 0.53% | -11.4% |
| Q3 2018 | $21,259,000 | +16.7% | 529,231 | +17.1% | 0.60% | +10.6% |
| Q2 2018 | $18,223,000 | +1068.9% | 452,051 | +1033.0% | 0.54% | +1025.0% |
| Q1 2018 | $1,559,000 | +26.4% | 39,898 | +14.8% | 0.05% | +23.1% |
| Q4 2017 | $1,233,000 | -91.3% | 34,755 | -90.0% | 0.04% | -91.3% |
| Q3 2017 | $14,113,000 | -3.1% | 347,620 | +2.9% | 0.45% | -7.2% |
| Q2 2017 | $14,564,000 | +2.6% | 337,757 | +0.3% | 0.48% | -0.6% |
| Q1 2017 | $14,194,000 | +4.5% | 336,668 | -4.5% | 0.49% | -0.6% |
| Q4 2016 | $13,577,000 | -52.0% | 352,556 | -46.3% | 0.49% | -53.9% |
| Q3 2016 | $28,290,000 | +13.5% | 655,924 | +14.0% | 1.06% | +10.4% |
| Q2 2016 | $24,934,000 | +2031.1% | 575,320 | +1894.0% | 0.96% | +1790.2% |
| Q1 2016 | $1,170,000 | +107.8% | 28,853 | +106.9% | 0.05% | +112.5% |
| Q4 2015 | $563,000 | +5.0% | 13,943 | +0.0% | 0.02% | 0.0% |
| Q3 2015 | $536,000 | -16.6% | 13,940 | -9.7% | 0.02% | -14.3% |
| Q2 2015 | $643,000 | +12.6% | 15,438 | +24.9% | 0.03% | +12.0% |
| Q1 2015 | $571,000 | +2.5% | 12,365 | -5.2% | 0.02% | 0.0% |
| Q4 2014 | $557,000 | -6.1% | 13,037 | +1.1% | 0.02% | -16.7% |
| Q3 2014 | $593,000 | -97.1% | 12,899 | -96.6% | 0.03% | -97.1% |
| Q2 2014 | $20,523,000 | +53.9% | 383,753 | +53.8% | 1.04% | +40.9% |
| Q1 2014 | $13,331,000 | +1.0% | 249,496 | +0.9% | 0.74% | -0.3% |
| Q4 2013 | $13,197,000 | +8.2% | 247,177 | +1.7% | 0.74% | -6.3% |
| Q3 2013 | $12,197,000 | +0.9% | 243,106 | +0.5% | 0.79% | +9.1% |
| Q2 2013 | $12,086,000 | – | 241,861 | – | 0.72% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SENZAR ASSET MANAGEMENT, LLC | 668,200 | $30,717,000 | 9.01% |
| Camber Capital Management LP | 1,200,000 | $55,164,000 | 5.18% |
| Camber Capital Management LP | 1,000,000 | $45,970,000 | 4.32% |
| Gary Goldberg Planning Services Inc | 178,496 | $8,205,000 | 3.41% |
| Hamlin Capital Management, LLC | 1,217,870 | $55,985,000 | 3.36% |
| Winch Advisory Services, LLC | 109,101 | $5,015,000 | 3.22% |
| NORTHROAD CAPITAL MANAGEMENT LLC | 151,701 | $6,974,000 | 2.69% |
| Reynders McVeigh Capital Management, LLC | 296,118 | $13,613,000 | 2.59% |
| SALEM CAPITAL MANAGEMENT INC | 120,520 | $5,540,000 | 2.58% |
| Keystone Financial Planning, Inc. | 74,338 | $3,417,000 | 2.58% |